Leslie Meltzer Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

APLS Quotes by TradingView

Leslie Meltzer is Chief Research and Development of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 61,804 shares of APLS, which is worth approximately $1.43 Million. The most recent transaction as insider was on Aug 26, 2025, when has been sold 61,804 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.8K
n/a 3M change
n/a 12M change
Total Value Held $1.43 Million

LESLIE MELTZER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2025
BUY
Grant, award, or other acquisition
-
61,804 Added 50.0%
61,804 Common Stock
LM

Leslie Meltzer

Chief Research and Development
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APLS